Rankings
▼
Calendar
XNCR Q1 2022 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena
XNCR
Xencor, Inc.
$890M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$85M
+151.7% YoY
Gross Profit
$38M
44.1% margin
Operating Income
$26M
31.0% margin
Net Income
$24M
27.6% margin
EPS (Diluted)
$0.39
QoQ Revenue Growth
-44.5%
Cash Flow
Operating Cash Flow
$6M
Free Cash Flow
$3M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$858M
Total Liabilities
$95M
Stockholders' Equity
$763M
Cash & Equivalents
$78M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$85M
$34M
+151.7%
Gross Profit
$38M
-$7M
+606.8%
Operating Income
$26M
-$16M
+268.9%
Net Income
$24M
-$2M
+1048.7%
Revenue Segments
Royalties
$79M
92%
Milestone
$5M
6%
Research collaboration
$2M
2%
← FY 2022
All Quarters
Q2 2022 →